Intranasal Midazolam in Children as a Pre-Operative Sedative

• Status: Completed
• Trial end date: 2014-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to see if adding a numbing medicine, xylocaine, to the nasal midazolam makes giving the midazolam easier and more comfortable without affecting how the midazolam works as a sedative.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bassett Healthcare
• Treatments: Hypnotics and Sedatives; Lidocaine; Midazolam

Criteria

Inclusion Criteria:

1. Children aged 18 months-7 years, scheduled for a minor otolaryngology (ENT) surgical procedure requiring mask anesthesia

2. American Society of Anesthesiologists (ASA) Class 1 or 2

3. Parent willing and able to provide written informed consent

4. Parent willing and able to complete the OBD VAS

Exclusion Criteria:

1. ASA Class 3 or greater

2. History of allergy to midazolam or xylocaine

3. Presence of acute respiratory infection at time of surgery

4. Parent unwilling or unable to provide informed consent

5. Parent unwilling or unable to complete the OBD VAS